01-09-2022 дата публикации
Номер: US20220274971A1
Принадлежит:
The present invention covers new isoquinoline compounds of general formula (I): 7. The compound according to claim 1 , wherein:{'sup': '2', 'claim-text': [{'sub': 3', '2, 'hydrogen, chlorine, iodine, —C(O)—N(CH),'}, {'sup': 12', '13, '—NRR;'}, {'sup': '14', '—OR;'}, {'sup': 15', '15', '15, 'sub': '2', '—SR, —S(O)R, —SOR;'}, {'sub': 2', '2', '3', '2', '3', '3, 'methyl, ethyl, propyl, isopropyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, ethenyl, propenyl, cyclopentenyl, cyclohexenyl, each of which is optionally substituted by 1 or 2 substituents independently selected from the group consisting of —OH, cyano, ethoxy-C(O)—, —C(O)—NH, methoxy, NH, N(CH), N(CH)(C(O)CH); and'}, {'sub': 2', '2', '2, 'a monocyclic or a bicyclic heterocycle selected from the group consisting of azetidine, oxetane pyrrolidine, tetrahydrofurane, pyrazolidine, imidazolidine, 1,2,4-triazolidine, piperidine, piperazine, tetrahydropyridine, dihydro-2H-pyrane, 1,2-oxazolidine, 1,2-oxazine, morpholine, thiomorpholine, 3,4-dihydroisoquinoline, 2,3-dihydro-indole, 1,3-dihydro-isoindoel, 3,9-dioxa-7-azabicyclo[3.3.1]nonane, 6-oxa-3-azabicyclo[3.1.1]heptane, 8-oxa-3-azabicyclo[3.2.1]octane, thiophene, imidazole, pyrazole, 1,2,4-triazole, 1,2,3-triazole, 1,2,3,4-tetrazole, pyridine, dihydropyridine pyrimidine, tetrahydropyrimidine, 4-oxa-7-azaspiro[2.5]octane, each of which is optionally substituted by 1, 2, 3 or 4 substituents independently selected from the group consisting of fluorine, chlorine, cyano —OH, oxo, —COOH, methoxy-C(O)—, ethoxy-C(O)—, tert-butoxy-C(O)—, —C(O)—NH, methyl, methyl-C(O)—, difluoromethyl, trifluoromethyl, hydroxymethyl-, methoxymethyl-, —NH, —NMe, pyrrolidine,'}], 'Ris selected from the group consisting of'}{'sup': 12', '13, 'claim-text': hydrogen, —NH(—C(O)-methyl), methoxy;', {'sub': 2', '2', '2', '2', '2', '2, 'methyl, ethyl, propyl, isopropyl, butyl, isobutyl, cyclopropyl, cyclobutyl, benzyl, 1-phenylethyl, each of which is optionally substituted by 1, 2 or 3 ...
Подробнее